[go: up one dir, main page]

RU2018107054A3 - - Google Patents

Download PDF

Info

Publication number
RU2018107054A3
RU2018107054A3 RU2018107054A RU2018107054A RU2018107054A3 RU 2018107054 A3 RU2018107054 A3 RU 2018107054A3 RU 2018107054 A RU2018107054 A RU 2018107054A RU 2018107054 A RU2018107054 A RU 2018107054A RU 2018107054 A3 RU2018107054 A3 RU 2018107054A3
Authority
RU
Russia
Application number
RU2018107054A
Other languages
Russian (ru)
Other versions
RU2018107054A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018107054A publication Critical patent/RU2018107054A/en
Publication of RU2018107054A3 publication Critical patent/RU2018107054A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
RU2018107054A 2015-07-28 2016-07-28 PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY AT STORAGE AND METHOD FOR PRODUCING IT RU2018107054A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2015-0106628 2015-07-28
KR1020150106628A KR101787447B1 (en) 2015-07-28 2015-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same
PCT/KR2016/008269 WO2017018819A1 (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Publications (2)

Publication Number Publication Date
RU2018107054A RU2018107054A (en) 2019-08-28
RU2018107054A3 true RU2018107054A3 (en) 2019-08-28

Family

ID=57884931

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018107054A RU2018107054A (en) 2015-07-28 2016-07-28 PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY AT STORAGE AND METHOD FOR PRODUCING IT

Country Status (13)

Country Link
EP (1) EP3328436A4 (en)
JP (1) JP2018521106A (en)
KR (1) KR101787447B1 (en)
CN (1) CN106659680A (en)
AU (1) AU2016299547A1 (en)
BR (1) BR112018001719A2 (en)
CA (1) CA2993923A1 (en)
HK (1) HK1249440A1 (en)
IL (1) IL257181A (en)
MX (1) MX2018001222A (en)
RU (1) RU2018107054A (en)
WO (1) WO2017018819A1 (en)
ZA (1) ZA201801186B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101787451B1 (en) * 2015-07-28 2017-10-19 주식회사 삼양바이오팜 Pharmaceutical composition with improved storage stability and method for preparing the same
US20190231689A1 (en) * 2018-01-29 2019-08-01 Samyang Biopharmaceuticals Corporation Amphiphilic Block Copolymer Composition With Enhanced Micelle Stability

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1280557B1 (en) * 2000-05-12 2012-06-20 Samyang Corporation Method for the preparation of polymeric micelle via phase separation of block copolymer
ATE370988T1 (en) * 2001-10-18 2007-09-15 Samyang Corp POLYMER MICELLE COMPOSITION WITH IMPROVED STABILITY
ES2353653T3 (en) 2007-03-06 2011-03-03 Cell Therapeutics Europe S.R.L. METHOD FOR DETERMINING THE AMOUNT OF CONJUGATED TAXAN IN POLYGLUTAMIC ACID-TAXAN CONJUGATES.
KR101024742B1 (en) * 2007-12-31 2011-03-24 주식회사 삼양사 Taxane-containing amphiphilic block copolymer micelle composition and preparation method thereof
US8853351B2 (en) * 2007-12-31 2014-10-07 Samyang Biopharmaceuticals Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
KR101787453B1 (en) * 2015-07-28 2017-10-19 주식회사 삼양바이오팜 Pharmaceutical composition with improved storage stability and method for preparing the same
KR101787451B1 (en) * 2015-07-28 2017-10-19 주식회사 삼양바이오팜 Pharmaceutical composition with improved storage stability and method for preparing the same

Also Published As

Publication number Publication date
CN106659680A (en) 2017-05-10
JP2018521106A (en) 2018-08-02
RU2018107054A (en) 2019-08-28
BR112018001719A2 (en) 2018-09-18
KR20170014059A (en) 2017-02-08
EP3328436A4 (en) 2019-03-20
CA2993923A1 (en) 2017-02-02
EP3328436A1 (en) 2018-06-06
WO2017018819A1 (en) 2017-02-02
IL257181A (en) 2018-03-29
KR101787447B1 (en) 2017-10-19
AU2016299547A1 (en) 2018-02-22
MX2018001222A (en) 2018-04-24
HK1249440A1 (en) 2018-11-02
ZA201801186B (en) 2018-12-19

Similar Documents

Publication Publication Date Title
BE2015C047I2 (en)
BE2015C044I2 (en)
BR0002802B1 (en)
BR0008604B1 (en)
BR0000763F1 (en)
BR0001536B1 (en)
BR0001684B1 (en)
BR0001810B1 (en)
BR0002033B1 (en)
BR0002402B1 (en)
BR0002435B1 (en)
BR0006854B1 (en)
BR0006634B1 (en)
BR0002874B1 (en)
BR0003166B1 (en)
BR0003189B1 (en)
BR0003208B1 (en)
BR0003401B1 (en)
BR0003686B1 (en)
BR0003746B1 (en)
BR0003751B1 (en)
BR0003928B1 (en)
BR0004687B1 (en)
BR0005041B1 (en)
BR0000695B1 (en)